BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 30165051)

  • 21. Effect of flexible sigmoidoscopy screening on colorectal cancer incidence and mortality: long-term follow-up of the randomised US PLCO cancer screening trial.
    Miller EA; Pinsky PF; Schoen RE; Prorok PC; Church TR
    Lancet Gastroenterol Hepatol; 2019 Feb; 4(2):101-110. PubMed ID: 30502933
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk of colorectal cancer seven years after flexible sigmoidoscopy screening: randomised controlled trial.
    Hoff G; Grotmol T; Skovlund E; Bretthauer M;
    BMJ; 2009 May; 338():b1846. PubMed ID: 19483252
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduced incidence and mortality from colorectal cancer with flexible-sigmoidoscopy screening: a meta-analysis.
    Shroff J; Thosani N; Batra S; Singh H; Guha S
    World J Gastroenterol; 2014 Dec; 20(48):18466-76. PubMed ID: 25561818
    [TBL] [Abstract][Full Text] [Related]  

  • 24. What influences the decision to participate in colorectal cancer screening with faecal occult blood testing and sigmoidoscopy?
    van Dam L; Korfage IJ; Kuipers EJ; Hol L; van Roon AH; Reijerink JC; van Ballegooijen M; van Leerdam ME
    Eur J Cancer; 2013 Jul; 49(10):2321-30. PubMed ID: 23571149
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Positive impact of a faecal-based screening programme on colorectal cancer mortality risk.
    Ibáñez-Sanz G; Milà N; Vidal C; Rocamora J; Moreno V; Sanz-Pamplona R; Garcia M;
    PLoS One; 2021; 16(6):e0253369. PubMed ID: 34191813
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Psychological effects of colorectal cancer screening: Participants
    Kirkøen B; Berstad P; Botteri E; Bernklev L; El-Safadi B; Hoff G; de Lange T; Bernklev T
    World J Gastroenterol; 2016 Nov; 22(43):9631-9641. PubMed ID: 27920484
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Screening for Colorectal Cancer Is Associated With Lower Disease Stage: A Population-Based Study.
    Kubisch CH; Crispin A; Mansmann U; Göke B; Kolligs FT
    Clin Gastroenterol Hepatol; 2016 Nov; 14(11):1612-1618.e3. PubMed ID: 27085763
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Participation in a population-based screening for colorectal cancer using the faecal immunochemical test decreases mortality in 5 years.
    Idigoras Rubio I; Arana-Arri E; Portillo Villares I; Bilbao Iturribarrria I; Martínez-Indart L; Imaz-Ayo N; de la Cruz M; de Castro V; López de Munain A; Torrejón Perez I; Gutiérrez-Ibarluzea I
    Eur J Gastroenterol Hepatol; 2019 Feb; 31(2):197-204. PubMed ID: 30543575
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A randomised study of screening for colorectal cancer using faecal occult blood testing: results after 13 years and seven biennial screening rounds.
    Jørgensen OD; Kronborg O; Fenger C
    Gut; 2002 Jan; 50(1):29-32. PubMed ID: 11772963
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Equivalency of fecal immunochemical tests and colonoscopy in familial colorectal cancer screening.
    Quintero E; Carrillo M; Gimeno-García AZ; Hernández-Guerra M; Nicolás-Pérez D; Alonso-Abreu I; Díez-Fuentes ML; Abraira V
    Gastroenterology; 2014 Nov; 147(5):1021-30.e1; quiz e16-7. PubMed ID: 25127679
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectiveness of flexible sigmoidoscopy screening in men and women and different age groups: pooled analysis of randomised trials.
    Holme Ø; Schoen RE; Senore C; Segnan N; Hoff G; Løberg M; Bretthauer M; Adami HO; Kalager M
    BMJ; 2017 Jan; 356():i6673. PubMed ID: 28087510
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Health benefits and cost-effectiveness of a hybrid screening strategy for colorectal cancer.
    Dinh T; Ladabaum U; Alperin P; Caldwell C; Smith R; Levin TR
    Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1158-66. PubMed ID: 23542330
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Time to benefit for colorectal cancer screening: survival meta-analysis of flexible sigmoidoscopy trials.
    Tang V; Boscardin WJ; Stijacic-Cenzer I; Lee SJ
    BMJ; 2015 Apr; 350():h1662. PubMed ID: 25881903
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Higher Adenoma Detection Rates at Screening Associated With Lower Long-Term Colorectal Cancer Incidence and Mortality.
    Cross AJ; Robbins EC; Saunders BP; Duffy SW; Wooldrage K
    Clin Gastroenterol Hepatol; 2022 Feb; 20(2):e148-e167. PubMed ID: 32931959
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-Term Follow-up of the Italian Flexible Sigmoidoscopy Screening Trial.
    Senore C; Riggi E; Armaroli P; Bonelli L; Sciallero S; Zappa M; Arrigoni A; Casella C; Crosta C; Falcini F; Ferrero F; Fracchia M; Giuliani O; Risio M; Russo AG; Visioli CB; Rosso S; Segnan N;
    Ann Intern Med; 2022 Jan; 175(1):36-45. PubMed ID: 34748376
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The incidence of colorectal cancer following a negative screening sigmoidoscopy: implications for screening interval.
    Doria-Rose VP; Levin TR; Selby JV; Newcomb PA; Richert-Boe KE; Weiss NS
    Gastroenterology; 2004 Sep; 127(3):714-22. PubMed ID: 15362026
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term risk of colorectal cancer in individuals with serrated polyps.
    Holme Ø; Bretthauer M; Eide TJ; Løberg EM; Grzyb K; Løberg M; Kalager M; Adami HO; Kjellevold Ø; Hoff G
    Gut; 2015 Jun; 64(6):929-36. PubMed ID: 25399542
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interval Colorectal Cancers following Guaiac Fecal Occult Blood Testing in the Ontario ColonCancerCheck Program.
    Paszat L; Sutradhar R; Tinmouth J; Baxter N; Rabeneck L
    Can J Gastroenterol Hepatol; 2016; 2016():4768728. PubMed ID: 27446842
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Flexible sigmoidoscopy in the PLCO cancer screening trial: results from the baseline screening examination of a randomized trial.
    Weissfeld JL; Schoen RE; Pinsky PF; Bresalier RS; Church T; Yurgalevitch S; Austin JH; Prorok PC; Gohagan JK;
    J Natl Cancer Inst; 2005 Jul; 97(13):989-97. PubMed ID: 15998952
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design, organization and management of a controlled population screening study for detection of colorectal neoplasia: attendance rates in the NORCCAP study (Norwegian Colorectal Cancer Prevention).
    Bretthauer M; Gondal G; Larsen K; Carlsen E; Eide TJ; Grotmol T; Skovlund E; Tveit KM; Vatn MH; Hoff G
    Scand J Gastroenterol; 2002 May; 37(5):568-73. PubMed ID: 12059059
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.